These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2120137

  • 21. Inhibition of aflatoxin B1-hepatocarcinogenesis in rats by beta-naphthoflavone.
    Gurtoo HL, Koser PL, Bansal SK, Fox HW, Sharma SD, Mulhern AI, Pavelic ZP.
    Carcinogenesis; 1985 May; 6(5):675-8. PubMed ID: 3924427
    [Abstract] [Full Text] [Related]

  • 22. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats.
    Cabral JR, Neal GE.
    Cancer Lett; 1983 Jun; 19(2):125-32. PubMed ID: 6411325
    [Abstract] [Full Text] [Related]

  • 23. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
    Kraupp-Grasl B, Huber W, Putz B, Gerbracht U, Schulte-Hermann R.
    Cancer Res; 1990 Jun 15; 50(12):3701-8. PubMed ID: 1971196
    [Abstract] [Full Text] [Related]

  • 24. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
    Bailey GS, Loveland PM, Pereira C, Pierce D, Hendricks JD, Groopman JD.
    Mutat Res; 1994 Aug 15; 313(1):25-38. PubMed ID: 7519308
    [Abstract] [Full Text] [Related]

  • 25. Dietary protein level and aflatoxin B1-induced preneoplastic hepatic lesions in the rat.
    Dunaif GE, Campbell TC.
    J Nutr; 1987 Jul 15; 117(7):1298-302. PubMed ID: 2886567
    [Abstract] [Full Text] [Related]

  • 26. The particular traits of carcinogenesis induced in Wistar rats by aflatoxin B1. III. Porphyrins and the activity of gamma-glutamyltranspeptidase in primary hepatomas and in their tissue of origin.
    Zawirska B, Bednarz W.
    Neoplasma; 1981 Jul 15; 28(1):35-49. PubMed ID: 6116200
    [Abstract] [Full Text] [Related]

  • 27. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M, Mostafa M, Sabry M, el-Farrash M, Yousef T.
    Hepatogastroenterology; 2008 Jul 15; 55(86-87):1754-9. PubMed ID: 19102385
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of hepatocarcinogenesis by adrenocorticotropin in aflatoxin B1-treated rats.
    Chedid A, Bundeally AE, Mendenhall CL.
    J Natl Cancer Inst; 1977 Feb 15; 58(2):339-49. PubMed ID: 189049
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Association of reduction of AFB1-induced liver tumours by antioxidants with increased activity of microsomal enzymes.
    Nyandieka HS, Wakhis J, Kilonzo MM.
    Indian J Med Res; 1990 Oct 15; 92():332-6. PubMed ID: 2125579
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
    Roebuck BD, Liu YL, Rogers AE, Groopman JD, Kensler TW.
    Cancer Res; 1991 Oct 15; 51(20):5501-6. PubMed ID: 1680553
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.